School of Medicine
Showing 12,301-12,400 of 13,148 Results
-
Chad S. Weldy, M.D., Ph.D.
Instructor, Medicine - Cardiovascular Medicine
Current Research and Scholarly InterestsAs a physician-scientist in the lab of Dr. Quertermous I work to understand the genetic basis of cardiovascular disease and the transcriptional and epigenomic mechanisms of atherosclerosis. My work is focused across four main areas of cardiovascular genetics and mechanisms of coronary artery disease and smooth muscle biology:
1.Vascular smooth muscle specific ADAR1 mediated RNA editing of double stranded RNA and activation of the double stranded RNA receptor MDA5
2.Defining on single cell resolution the cellular and epigenomic features of human vascular disease across vascular beds of differing embryonic origin
3.CRISPRi screening with targeted perturb seq (TAPseq) to identify novel CAD genes in human coronary artery smooth muscle cells
4.Investigation of the epigenetic and molecular basis of coronary artery disease and smooth muscle cell transition in mice with conditional smooth muscle genetic deletion of CAD genes Pdgfd and Sox9
My work with Dr. Quertermous is focused on discovery of causal mechanisms of disease through leveraging human genetics with sophisticated molecular biology, single cell sequencing technologies, and mouse models of disease. This work attempts to apply multiple scientific research arms to ultimately lead to novel understandings of vascular disease and discover important new therapeutic approaches for drug discovery.
Grant funding received for this work:
Mentored Clinical Scientist Research Career Development Award (K08)(NIH/NHLBI, 1 K08 HL167699-01), Submitted June, 2022. PI: Weldy, Chad
•Title of proposal: “ADAR Mediated RNA editing is a causal mechanism in coronary artery disease”.
•Pending 08/01/2023 Start date
•$850,000 over 5 years
Career Development Award, American Heart Association (AHA CDA)(23CDA1042900), July, 2023 – June, 2026. PI: Weldy, Chad
•Title of proposal: “Linking RNA editing to coronary artery calcification and disease”
•Activation on 07/01/2023
•$231,000 over three years
NIH Loan Repayment Program (LRP) Award (NIH/NHLBI) Renewal Award, July, 2023. PI: Weldy, Chad
•Title of proposal: “RNA editing is a causal mechanism of coronary artery disease”
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (F32) (NIH/NHLBI, 1 F32 HL160067-01), July, 2021. PI: Weldy, Chad
• Titled, “A transcriptional network which governs smooth muscle transition is mediated by causal coronary artery disease gene PDGFD”
•*Received perfect score with impact score 10, 1st percentile
NIH Loan Repayment Program (LRP) Award (NIH/NHLBI), July, 2021. PI: Weldy, Chad
•Title of proposal: "Single cell transcriptomic and epigenomic features of human atherosclerosis".
•This will award up to $100,000 towards student loans over the next 24 months with opportunity for renewal after 24 months. -
Andy Wen
Clinical Associate Professor, Pediatrics - Critical Care
BioDr. Andy Y. Wen joined the Division of Pediatric Critical Care Medicine at Stanford University School of Medicine as Clinical Associate Professor of Pediatrics in 2019. He received his B.A. degree in Molecular Biology & Biochemistry at Rutgers University, and his medical degree from Rutgers Robert Wood Johnson Medical School. He completed a Pediatrics Residency Training Program at the State University of New York Downstate Medical Center and a Pediatric Critical Care Medicine Fellowship Training Program at the University of California Los Angeles.
After briefly working for Kaiser Permanente Southern California Permanente Medical Group, Dr. Wen joined the Division of Pediatric Critical Care at NYU School of Medicine. He assumed the role of Bellevue Hospital PICU medical director and helped to expand Bellevue's Pediatric Trauma Program and Pediatric Critical Care Transport Services for the New York City (NYC) public hospital system, NYC Health & Hospitals. During the 2014 to 2016 Ebola outbreak in West Africa, Dr. Wen was a member of the Special Pathogens Program at Bellevue Hospital, which was one of only four institutions in the US to treat a patient with Ebola and helped established the National Ebola Training and Education Center (NETEC).
While at UCLA, Dr. Wen received a T32 Training Grant to perform research investigating the role of transcription factor CREB in innate immune function using a murine model for AML. At NYU, his research projects included analyzing transfusion practices in the PICU, quality improvement projects targeting patients at high risk for unplanned extubation, and exploring the utility of NIRS as an early predictor of seizure activity. Dr. Wen is a member of Pediatric Acute Lung Injury & Sepsis Investigators (PALISI) and has been involved in multi-center studies looking at critical care patients with Bronchiolitis and COVID-19. Dr. Wen is the USA Editor for Journal of Pediatric Intensive Care and has reviewed abstracts for PAS, SCCM, and AMIA. His educational efforts have included teaching Pediatric Fundamental Critical Care Support (PFCCS) courses, helping develop a Pediatric Residency Simulation course curriculum, and helping develop a Point-of-Care Ultrasound course for critical care advanced practice providers.
At Stanford University School of Medicine, Dr. Wen is in charge of Regional Pediatric Critical Care Outreach with a goal to promote medical education and expand the Stanford Children’s Health network to improve access for sick children in need of high quality care. Dr. Wen provides clinical services at both John Muir Medical Center and Lucile Packard Children’s Hospital. -
Gerald Wen
IT Manager, Anesthesia
Current Role at StanfordIT Manager
Tuesday/Thursday @ Redwood City Campus, Discovery Hall -
Rain Runxia Wen
Postdoctoral Scholar, Ophthalmology
BioRain Runxia Wen obtained her B.Sc. (Hons) in biology in 2012, and her Ph.D. degree in cell and developmental biology in 2018. She joined the Goldberg Lab in the Department of Ophthalmology at Stanford University in 2019. She is currently developing epigenetic tools to promote neuroregeneration, especially retinal ganglion cell, and optic nerve regeneration.
-
Ru M Wen
Postdoctoral Scholar, Urology
BioI am dedicated to understanding the role of glycoproteins in prostate cancer, with a primary focus on Siglec-based immunotherapy. My research aims to elucidate how glycoproteins, such as AZGP1 and FXYD5, affect tumor progression and immune regulation.
-
Paul Wender
Francis W. Bergstrom Professor and Professor, by courtesy, of Chemical and Systems Biology
Current Research and Scholarly InterestsMolecular imaging, therapeutics, drug delivery, drug mode of action, synthesis
-
Kirsti Weng Elder MD/MPH
Clinical Associate Professor, Medicine - Primary Care and Population Health
BioDr. Weng is the Section Chief of General Primary Care. She has over 25 years of experience caring for patients in primary care, urgent care and in the hospital. She is also a teacher of students and residents. As a leader in primary care re-design, she is passionate about practicing patient-centered medicine. She is a an advocate of Mindfulness Self-compassion to develop equanimity. She practices with an emphasis on musculoskeletal care as she feels fitness is the foundation of wellness. She is a leader in organizational change and physician management. She supports community health and care for the underserved. Outside of work she enjoys biking, reading and spending time with her 8 children.
-
Wen-Kai Weng, MD, PhD
Associate Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy) and, by courtesy, of Dermatology
Current Research and Scholarly InterestsMy research interest is on immunotherapy (including allogeneic transplant) of cancer. I have studies the mechanism of monoclonal antibody therapy in lymphoma patients and am currently working on designing new strategy to enhance the clinical efficacy of antibody therapy by infusing expanded NK cells. I am also interested in using tumor vaccine along with hematopoietic cell transplant.
-
Yingjie Weng
Biostatistician 3, Med/Quantitative Sciences Unit
Current Role at StanfordResponsibility for Assistant Director, Learning Health Systems Program (LHS):
• Establish and update LHS program resources within QSU
• Host the onboard training program for new QSU hires and training sessions at a regular basis within QSU
• Establish and mentor a core team within QSU for the LHS program
• Guide the process of the projects assignments for quality improvement, pragmatic trials and studies involve real-world evidence generation using electronic health records (EHRs)
• Maintain close relationships with clinical advocators of LHS projects at our collaborating departments under the supports and advocacy of QSU leadership.
• Host an on-board session with department leaders who are interested in the program to communicate our missions of the program.
• Host educational sessions/lectures for clinical investigators across collaborating departments
• Establish close collaborations with a variety of data teams across campus departments under the supports and advocacy of QSU leadership
• Act as the point person for QSU on the LHS Program
Responsibility for Senior Biostatistician:
- Study Design and Study Protocol Development
- Statistical Analysis Plan
- Grant Preparation
- Statistical Methodology Research
- Data Quality Control
- Data Visualization
- Data Cleaning
- Statistical Programming
- Statistical Modeling
- Mentor junior statistician -
Zhenzhen Weng
Research Asst - Graduate, Biomedical Data Science
BioI am a final year Ph.D student in Computational and Mathematical Engineering (ICME) at Stanford University where I am advised by Prof. Serena Yeung.
I am broadly interested in 3D computer vision and machine learning. Specifically, my current research interests are human-centric 3D perception.
Prior to my Ph.D, I received B.S. in Computer Science and B.S. in Mathematics from Carnegie Mellon University. I also previously worked for a fund manager on the East Coast.
My website: https://zzweng.github.io/ -
Gerlinde Wernig
Assistant Professor of Pathology
Current Research and Scholarly InterestsFibrotic diseases kill more people than cancer in this country and worldwide. We believe that scar-forming cells called fibroblasts are at the core of the fibrotic response in parenchymal organ fibrosis in the lung, liver, skin, bone marrow and tumor stroma. At the cellular level we think of fibrosis as a step wise process which implicates inflammation and fibrosis. We seek to identify new effective immune therapy targets to treat fibrotic diseases.
-
Marius Wernig
Professor of Pathology and, by courtesy, of Chemical and Systems Biology
Current Research and Scholarly InterestsEpigenetic Reprogramming, Direct conversion of fibroblasts into neurons, Pluripotent Stem Cells, Neural Differentiation: implications in development and regenerative medicine
-
Lauren (Lo) Wesson-Stout
Temporary Employee, Clinical Excellence Research Center (CERC) Operations
BioLauren (Lo) Wesson-Stout earned her BSN at the University of South Florida (go Bulls!) in 2013 and is a recent graduate of Georgetown University’s Adult-Gerontology Acute Care Nurse Practitioner program. She is board certified through the American Nurses Credentialing Center and is a member of the Neurocritical Care Society and the American Association of Critical-Care Nurses. Lo has seven years of bedside critical care nursing experience and has worked with a variety of patient populations including neurology, surgical, and trauma.
-
Dee W. West
Professor of Health Research and Policy, Emeritus
Current Research and Scholarly Interests- Cancer etiology (diet, familial, genetic), especially breast, prostate and colon cancer
- Cancer surveillance (Cancer registration, cancer patterns)
- Cancer outcomes (Survival, quality of life, quality of care) -
Robert West
Professor of Pathology
Current Research and Scholarly InterestsRob West, MD, PhD, is a Professor of Pathology at Stanford University Medical Center. He is a clinician scientist with experience in translational genomics research to identify new prognostic and therapeutic markers in cancer. His research focus is on the progression of neoplasia to carcinoma. His lab has developed spatially oriented in situ methods to study archival specimens. He also serves as a surgical pathologist specializing in breast pathology.
-
Lynn Marie Westphal, M.D.
Professor of Obstetrics and Gynecology (Reproductive Endocrinology and Infertility) at Stanford University Medical Center, Emerita
Current Research and Scholarly InterestsInfertility, fertility preservation, oocyte cryopreservation
-
Cornelia Weyand
Professor of Medicine (Immunology and Rheumatology), Emerita
Current Research and Scholarly InterestsAutoimmunity
Chronic inflammatory disease
Metabolic control of immune function -
Christopher Weyant
Temp - Non-Exempt, Health Policy
BioI am a Postdoctoral Scholar in Primary Care and Outcomes Research. I previously completed a PhD in Management Science and Engineering, MS in Bioengineering, and BS in Chemical Engineering at Stanford. In my postdoc, I am developing and applying data-driven methods and models to inform complex health policy decisions surrounding infectious diseases.
-
Jessica Whalen, MS
Adm Svcs Admstr 3, Peds/Child Health Research Program
Current Role at StanfordProgram Director (PEDSnet) & Data Manager (Stanford Assessments of Bone Across the ages (SAMBA Center))
-
Matthew Wheeler
Associate Professor of Medicine (Cardiovascular Medicine)
Current Research and Scholarly InterestsTranslational research in rare and undiagnosed diseases. Basic and clinical research in cardiomyopathy genetics, mechanisms, screening, and treatment. Investigating novel agents for treatment of hypertrophic cardiomyopathy and new mechanisms in heart failure. Cardiovascular screening and genetics in competitive athletes, disease gene discovery in cardiomyopathy and rare disease. Informatics approaches to rare disease and multiomics. Molecular transducers of physical activity bioinformatics.
-
Evans Whitaker
Temp - Non-Exempt, School of Medicine - Lane Medical Library
Current Role at StanfordResearch and Instruction Librarian Lane Medical Library
-
Lee White, Ph.D.
Clinical Scholar, Urology
Fellow in UrologyBioI am a fourth year clinical medical student at Stanford University School of Medicine. Here you will find out about my interests including a list of my publications and projects. I completed my doctoral research on training and evaluation of robotic surgical techniques with the Biorobotics Lab at the University of Washington in Spring 2013. I am a co-founder of C-SATS, Inc., a surgical performance assessment company that uses expert reviews and the wisdom of the crowd to train surgeons and medical practitioners.
-
Shannon White
Postdoctoral Scholar, Genetics
BioHi, I'm Shannon White. I began my postdoctoral fellowship in Michael Snyder's lab in the fall of 2020. I received my PhD from Georgetown University in Tumor Biology in Chunling Yi's lab. My graduate worked explore the signaling and metabolic vulnerabilities of NF2-mutant tumors following YAP/TAZ depletion. My postdoctoral work is exploring the epigenetic hallmarks that contribute to colon cancer progression and drug resistance. I am developing colon organoids derived from pre-cancerous polyp tissue collected from Familial Adenomatous Polyposis patients as a model system to investigate epigenetic and signaling responses to chemoprevention treatments.
-
Zachary Bruce White II
Affiliate, Department Funds
Resident in Radiation Oncology - Radiation TherapyBioI’m originally from Birmingham, AL. I completed my undergraduate education at Tuskegee University and majored in Biology/Pre-Health and minored in Bioethics. I also received a Master of Science in Biomedical & Health Sciences from the University of Alabama at Birmingham and completed medical school at the University of South Alabama College of Medicine. Following graduation from medical school, my intern year was spent in my hometown at Brookwood Baptist Health Transitional Year Program. One of my favorite aspects of radiation oncology at Stanford is the opportunity to give compassionate medical care to our cancer patients while working with the latest state-of-the-art medical technology. In my free time I enjoy playing tennis, exercising, traveling, trying new restaurants, and spending time with my family & friends.
-
John Whitin
Senior Research Scientist, Pediatrics
Current Role at StanfordSenior Research Scientist
-
Ian Whitmore
Professor (Teaching) of Surgery (Anatomy)
On Leave from 05/15/2024 To 08/25/2024Current Research and Scholarly InterestsThe development of better regimes for teaching Anatomy using Cadavers.
-
Malinda Whitney, MSN, RN, AGACNP-BC
Affiliate, Orthopaedic Surgery
BioMalinda Whitney, MSN, RN, AGACNP-BC, is an advanced practice provider who specializes in Orthopedics. She graduated with her Adult Gerontological Acute Care Nurse Practitioner (AGACNP) degree at the University of South Alabama. Malinda Whitney also completed an orthopedic fellowship program at Duke University School of Nursing. Her area of expertise is orthopedics, specializing in disorders of the foot and ankle.
-
Alice S Whittemore
Professor of Health Research and Policy (Epidemiology) and of Biomedical Data Science, Emerita
Professor Emerita, Epidemiology and Population HealthCurrent Research and Scholarly InterestsCancers of the prostate, breast and ovary account for a major proportion of new cancer cases and cancer deaths in the U.S. each year. Our recent research focus has been on developing improved statistical methods for the design and conduct of studies involving hereditary predisposition and modifiable lifestyle characteristics in the etiologies of site-specific cancers.
-
Aileen Whyte
Clinical Associate Professor, Psychiatry and Behavioral Sciences - Child & Adolescent Psychiatry and Child Development
BioDr. Aileen Whyte, a licensed psychologist in California, brings over two decades of specialized expertise to the treatment of eating disorders in young people. Beyond her clinical practice, Dr. Whyte actively works on implementing strategies to expand the reach of evidence-based treatments for eating disorders, aiming to make these best-practice interventions more accessible to a wider population.
Dr Whyte serves as the Director of the Stanford Outpatient Child & Adolescent Eating Disorders Clinic, where she provides treatment to young people with eating disorders and provides supervision to psychology and psychiatry fellows. Dr Whyte is a certified practitioner and consultant in Family-Based Treatment (FBT) for eating disorders. She serves as a study therapist in NIMH-sponsored randomized clinical trials focused on examining FBT and related adaptations.
In addition to her clinical responsibilities, Dr. Whyte has led multiple seminars, workshops, and training sessions dedicated to the treatment of eating disorders. She provides ongoing training and consultation in FBT, reaching diverse audiences, including multidisciplinary clinicians, psychologists, and psychiatrists, within the US and internationally.
Dr. Whyte earned her PhD in Clinical Psychology from the New School for Social Research in New York. Her research and clinical interests converge on the implementation and dissemination of evidence-based treatments for eating disorders. -
Britni Wilcher
Postdoctoral Scholar, Health Policy
BioBritni Wilcher, PhD, is a Postdoctoral Fellow in Health Services Research & Development. Dr. Wilcher earned her PhD in economics from American University in 2022. She is an applied microeconomist with interests in health, labor, and gender economics. Dr. Wilcher’s research focuses on the economics of health decision making and its implications for labor markets using quasi-experimental designs to draw causal inferences for historically disadvantaged populations. While completing her doctoral studies, Dr. Wilcher also conducted impact analysis of US regulations for think tanks and government agencies.
Prior to her doctoral studies, Dr. Wilcher completed a BA in Economics at Spelman College and MSc in International Health Care Management, Economics, and Policy at SDA Bocconi School of Management in Milan, Italy. During her masters, she specialized in the economics evaluation of pharmaceutical and medical devices. Dr. Wilcher applied that training as a senior consultant at Booz Allen Hamilton in Washington, DC and research fellow at the University of Exeter in England. Her work at Exeter, supporting an EU commission aimed at advancing the existing methodological framework for health technology assessment (HTA) of medical devices (MedtecHTA), was published in Value in Health, Health Economics, and the International Journal of Technology Assessment in Health Care. -
Rob W.
Biomedical Engineer, Radiology - Diagnostic Radiology
Current Role at StanfordSupport medical 3D imaging and point-of-care clinical 3D printing for Stanford Healthcare and LPCH!
-
Kevin Wilkins
Science Engineering Assoc 2, Neurology
Current Role at StanfordScience and Engineering Associate
-
Sierra Hewett Willens
MD Student with Scholarly Concentration in Informatics & Data-Driven Medicine / Women's Health - Sexual & Gender Minority Health, expected graduation Spring 2025
BioSierra Willens is a medical student at Stanford interested in the intersection of healthcare and technology. In 2018 she was awarded a fellowship with Guangzhou Women and Children's Hospital to conduct AI research designed to combat socioeconomic and geographic barriers to medicine through scientific innovation. Her contributions have been recognized through numerous accolades with publications in Cell and Nature Medicine and over 3K citations in the literature. Her projects range from developing AI models for early detection of retinal diseases to predicting preterm birth and craniofacial abnormalities from perinatal ultrasounds, and assessing post-operative surgical outcomes using automated hand keypoint detection. Sierra has published seven chapters, served as a reviewer for medical journals, and was a contributor to the book, “Regenerative Facial Surgery.” Her work on regenerative facial aesthetics earned the Tiffany Award for Best Scientific Presentation. Through these pursuits, he research has earned her the Discovery Grant, Innovation Grant, and a year-long research fellowship from Stanford's MedScholars program. Lastly, Sierra received the Special Projects Initiatives Funding (SPIF) grant for cofounding Stanford's new MEDXBioDesign student initiation: a coalition between Biodesign and Stanford School of Medicine, designed to lead future generations of physicians on how to become critical, impactful collaborators in the sector of health care innovation.
-
Jennifer Williams
Clinical Assistant Professor, Medicine - Pulmonary, Allergy & Critical Care Medicine
BioDr. Williams is a fellowship-trained pulmonologist specializing in pulmonary critical care medicine. She has board certification in pulmonary medicine, critical care medicine, and internal medicine.
She is a clinical assistant professor in the Department of Medicine, Division of Pulmonary, Allergy & Critical Care Medicine at Stanford University School of Medicine.
For each patient, Dr. Williams develops a comprehensive and compassionate care plan. Her goal is to help every individual achieve the best possible lung health and quality of life.
Patient reviews praise the quality of the care she delivers, her thoroughness, and her patient skills.
Dr. Williams has participated in clinical research studies. She has published articles on autoimmune disease involving interstitial lung disease, COPD, and life-threatening pulmonary complications associated with leukemia. She also co-authored an article on the development of guidelines for identifying and managing post-traumatic stress disorder symptoms associated with critical illness.
Her work has appeared in peer-reviewed journals including the American Journal of Respiratory and Critical Care Medicine, Internal Medicine, and elsewhere. She also has written chapters in books on critical care medicine and clinical decision-making.
Dr. Williams speaks English and both written and oral medical Spanish. In her free time, she enjoys soccer and distance running. -
Leanne Williams
Vincent V.C. Woo Professor, Professor of Psychiatry and Behavioral Sciences (Major Laboratories and Clinical Translational Neurosciences Incubator) and, by courtesy, of Psychology
Current Research and Scholarly InterestsA revolution is under way in psychiatry. We can now understand mental illness as an expression of underlying brain circuit disruptions, shaped by experience and genetics. Our lab is defining precision brain circuit biotypes for depression, anxiety and related disorders. We integrate large amounts of brain imaging, behavioral and clinical data and computational approaches. Biotypes are used in personalized intervention studies with selective drugs, neuromodulation and exploratory therapeutics.
-
Nolan Williams
Associate Professor of Psychiatry and Behavioral Sciences (Major Laboratories & Clinical Translational Neurosciences Incubator) and, by courtesy, of Radiology (Neuroimaging and Neurointervention)
BioNolan Williams, M.D. is an Associate Professor of Psychiatry and Behavioral Sciences at Stanford University and Director of the Stanford Brain Stimulation Lab. The long-term goals of his research program are to develop innovative technologies and therapeutics capable of modulating the neural circuitry disrupted in mood disorders, OCD, and other neuropsychiatric conditions. His team has been developing neuroimaging-based approaches to precisely target therapeutic delivery and predict treatment responses to therapeutic neuromodulation and psychedelics. Dr. Williams earned his M.D. and completed his dual residencies in neurology and psychiatry at the Medical University of South Carolina (MUSC). Triple board-certified in general neurology, general psychiatry, as well as behavioral neurology and neuropsychiatry, Dr. Williams brings a comprehensive background in clinical neuroscience to his role as a clinically active neuropsychiatrist. His expertise extends to the development and implementation of novel therapeutics, including devices and novel compounds, for central nervous system illnesses.
Over the past decade, Dr. Williams’ laboratory alongside collaborators at Stanford University have pioneered multiple novel therapeutic and human neuroscience approaches. Notably, Stanford Accelerated Intelligent Neuromodulation Therapy (SAINT) is the world's first non-invasive, rapid-acting neuromodulation approach for treatment-resistant depression. SAINT received FDA Breakthrough Device Designation Status (2021) and FDA Clearance (2022) and is the first psychiatric treatment to be covered by Medicare New Technology Add-On Payment (NTAP). As of April 2024, SAINT has been reimbursed for patients suffering from severe depression within inpatient psychiatric units. The SAINT technology is being deployed both clinically and in research protocols in laboratories and hospitals worldwide. Dr. Williams also has an expertise in psychedelic medicines for neuropsychiatric illness and is the first investigator to conduct mechanistic clinical trials exploring the neurobiological effects of ibogaine.
His research accomplishments have garnered international recognition, earning prestigious awards from the Pritzker Neuropsychiatric Disorders Consortium, One Mind Institute, Wellcome Leap Foundation, International Brain Stimulation Conference, National Institute of Mental Health (Biobehavioral Research Award for Innovative New Scientists), Society of Biological Psychiatry (A. E. Bennett Award), along with multiple awards from the Brain Behavior Research Foundation (most notably the Gerald L. Klerman Award). His work has been featured in Scientific American, The New York Times, The Washington Post, USA Today, CBS Sunday Morning, and the TODAY Show. -
Rokeena Williams
eLearning Manager, School of Medicine - Post Grad Med Education (CME)
Current Role at StanfordeLearning Manager
-
Sarah R. Williams MD, MHPE, PCC
Clinical Professor, Emergency Medicine
Current Research and Scholarly InterestsExploring ways to incorporate coaching into medical education.
Investigating ways to innovate medical education training across specialties.
Investigating applications of clinician-performed point-of-care ultrasound for emergency and critical care patients.
Improving safety of transitions of care between providers during sign-out. -
Sharon E. Williams PhD
Clinical Professor, Psychiatry and Behavioral Sciences - Child & Adolescent Psychiatry and Child Development
Current Research and Scholarly InterestsDr. Williams work focuses primarily on cognitive and emotional recovery of children who have been medically compromised. With improved medical treatment and increased survival rates comes the need to better understand the challenges that patients face following a life threatening illness or injury. Dr. Williams utilizes neuropsychological assessments to understand the cognitive abilities of children who have been diagnosed with cancer, head injuries, genetic disorders and other medical conditions.
-
Julie Williamson, DO, FAAP
Clinical Associate Professor, Anesthesiology, Perioperative and Pain Medicine
Clinical Associate Professor (By courtesy), Pediatrics - Critical CareBioDr. Williamson practices pediatric anesthesiology and critical care. She is committed to undergraduate and graduate medical education, and has served as an Educator-for-CARE at the Stanford School of Medicine and as a program director for Anesthesiology at Emory University. She is affiliated with several mentoring and advising programs, including the Stanford Anesthesiology Mentoring Program and the Women's Empowerment and Leadership Initiative for Pediatric Anesthesiologists.
-
Darrell Wilson
Professor of Pediatrics (Endocrinology) at the Lucile Salter Packard Children's Hospital, Emeritus
Current Research and Scholarly InterestsMy research interests cover a number of areas in Pediatric Endocrinology and Diabetes. I am PI of the Stanford Center for the NIH-funded Type-1 Diabetes TrialNet group. TrialNet conducts clinical trials directed at preventing or delaying the onset of Type 1 diabetes. I am an investigator in DirecNet, another NIH-funded study group, which is devoted to evaluating glucose sensors and the role of technology on the management of diabetes.